Research interests
Beyond LDL-C: Modern Lipid Management for ASCVD Prevention in Primary Care[7]
From 2026
AS
Adhir Shroff
As of 2004 · Current relationship
As of 2004 · Current relationship
Adhir Shroff is an interventional cardiologist and academic cardiovascular leader whose work spans procedural care, physician education, and health-system innovation. He earned his MD from the University of Chicago in 1996, completed internal medicine and chief residency at the University of Michigan, and pursued cardiovascular disease and interventional cardiology fellowships at Beth Israel Deaconess Medical Center. Shroff joined the University of Illinois Chicago faculty in 2004 and has held leadership roles including Interim Chief of Cardiology, Clinical Chief of Interventional Cardiology, and director of the cardiac catheterization laboratories. His research interests include cardiovascular outcomes, transcatheter aortic valve replacement, interventional hypertension, lipid management, and socioeconomic influences on cardiovascular care. He is also listed as an Adjunct Lecturer in Cardiology at Northwestern.
Each topic is linked to its supporting source in Sources.
Training includes Advanced training in finance at University of Pennsylvania’s Wharton School, Interventional Cardiology fellowship at Beth Israel Deaconess Medical Center, Cardiovascular Disease fellowship at Beth Israel Deaconess Medical Center, and Internal Medicine residency at University of Michigan, plus 5 more records.
Explore education and trainingAs of 2004
2021
As of 2021
2020
As of 2019
As of 2019
As of 2019
2013
2010
2010
2009
2008
2007
2006
2006
2005
As of 2004
As of 2003
As of 2000
1996
As of 1996
1991
Beyond LDL-C: Modern Lipid Management for ASCVD Prevention in Primary Care[7]
From 2026
Cardiovascular outcomes and health systems innovation[9]
Cracking the Zip Code: Uncovering the Link Between Socioeconomic Status and Transcatheter Aortic Valve Replacement Outcomes[7]
From 2025
Developing proficiency in a transcatheter aortic valve replacement program: lessons from a single academic center’s learning curve[7]
From 2026
Resistant Blood Pressure: New Frontiers in Interventional Hypertension Therapy[7]
From 2025